tradingkey.logo

Alpha Teknova Inc

TKNO
查看详细走势图
4.460USD
-0.190-4.09%
收盘 12/22, 16:00美东报价延迟15分钟
238.72M总市值
亏损市盈率 TTM

Alpha Teknova Inc

4.460
-0.190-4.09%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-4.09%

5天

-2.83%

1月

+3.72%

6月

-19.78%

今年开始到现在

-46.59%

1年

-42.30%

查看详细走势图

TradingKey Alpha Teknova Inc股票评分

单位: USD 更新时间: 2025-12-22

操作建议

Alpha Teknova Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名94/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价9.00。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Alpha Teknova Inc评分

相关信息

行业排名
94 / 208
全市场排名
223 / 4578
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 6 位分析师
买入
评级
9.000
目标均价
+96.51%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Alpha Teknova Inc亮点

亮点风险
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
业绩增长期
公司处于发展阶段,最新年度总收入37.74M美元
估值低估
公司最新PE估值-13.37,处于3年历史低位
机构减仓
最新机构持股45.32M股,环比减少3.55%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值5.03K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.20

Alpha Teknova Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Alpha Teknova Inc简介

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
公司代码TKNO
公司Alpha Teknova Inc
CEOGunstream (Stephen)
网址https://www.teknova.com/

常见问题

Alpha Teknova Inc(TKNO)的当前股价是多少?

Alpha Teknova Inc(TKNO)的当前股价是 4.460。

Alpha Teknova Inc的股票代码是什么?

Alpha Teknova Inc的股票代码是TKNO。

Alpha Teknova Inc股票的52周最高点是多少?

Alpha Teknova Inc股票的52周最高点是10.370。

Alpha Teknova Inc股票的52周最低点是多少?

Alpha Teknova Inc股票的52周最低点是3.940。

Alpha Teknova Inc的市值是多少?

Alpha Teknova Inc的市值是238.72M。

Alpha Teknova Inc的净利润是多少?

Alpha Teknova Inc的净利润为-26.75M。

现在Alpha Teknova Inc(TKNO)的股票是买入、持有还是卖出?

根据分析师评级,Alpha Teknova Inc(TKNO)的总体评级为买入,目标价格为9.000。

Alpha Teknova Inc(TKNO)股票的每股收益(EPS TTM)是多少

Alpha Teknova Inc(TKNO)股票的每股收益(EPS TTM)是-0.334。
KeyAI